SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-352755
Filing Date
2021-12-09
Accepted
2021-12-09 17:01:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d243318d424b5.htm 424B5 393835
2 GRAPHIC g243318g01a01.jpg GRAPHIC 109036
3 GRAPHIC g243318g01g01.jpg GRAPHIC 66486
4 GRAPHIC g243318g01k00.jpg GRAPHIC 40843
  Complete submission text file 0001193125-21-352755.txt   684935
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254661 | Film No.: 211482649
SIC: 2834 Pharmaceutical Preparations